Dehui Zou - Concepedia

Author

Dehui Zou

Institute of Hematology & Blood Diseases Hospital ORCID

Also Known As

D H Zou, D Zou, D. Zou, D.-H. Zou, Danping Zou, Daoyuan Zou, Datao Zou, De-Hui Zou, De-hui ZOU, De-hui Zou

511

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Henan Cancer Hospital Tianjin Medical University Cancer Institute and Hospital Jilin University

About

Dehui Zou is an author at Institute of Hematology & Blood Diseases Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	27	942
2	Health Sciences	9	9	418
3	Public Health	1	1	14
4	Allergy	1	1	20
5	Biomedical Engineering	1	1	16

Dehui Zou

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase Yuqin Song, Keshu Zhou, Dehui Zou, Clinical Cancer Research	2020	176
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study Yuqin Song, Quanli Gao, Huilai Zhang, Leukemia	2019	153
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study Yuqin Song, Keshu Zhou, Dehui Zou, Blood Long-term EfficacyPathologyPharmacotherapyHematological MalignancyOncology	2022	143
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia Runxia Gu, Fang Liu, Dehui Zou, Journal of Hematology & Oncology	2020	107
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma Lihui Shi, Xiaoqi Qin, Huijun Wang, Oncotarget PrognosisImmunologyPathologyImmunotherapyMyeloid Neoplasia	2016	105
Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China Zhitao Ying, Haiyan Yang, Ye Guo, Cancer Medicine	2020	98
Regulation of p53‐targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma Michael W. Gordon, Fang Yan, Xiaoming Zhong, Molecular Carcinogenesis	2014	90
The Impact of Clone Size on the Prognostic Value of Chromosome Aberrations by Fluorescence <i>In Situ</i> Hybridization in Multiple Myeloma Gang An, Zengjun Li, Yu‐Tzu Tai, Clinical Cancer Research	2015	89
Crystal‐storing histiocytosis: a clinicopathological study of 13 cases Rashmi Kanagal‐Shamanna, Zijun Y. Xu‐Monette, Roberto N. Miranda, Histopathology	2015	83
Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization Fengyan Jin, Qiong-Li Zhai, L. Qiu, Bone Marrow Transplantation Cell TherapyMedicineStem Cell MobilizationImmunologyHematology	2008	74

Page 1